Post by Alira Health

As the biologics CDMO market matures, public market valuations continue to reflect meaningful differences in scale, integration, and strategic positioning across platforms. Our latest Biologics CDMO Public Market Report examines how valuations, capital allocation, and competitive dynamics are evolving across the sector, highlighting the growing divide between leading integrated platforms and the broader CDMO market. The report also explores key industry trends shaping the landscape, including capacity constraints, strategic transactions, demand for high-volume biologics, and the increasing importance of geographically diversified manufacturing networks. 📈 Preview the report below and access the full analysis for insights into biologics CDMO valuation trends, competitive dynamics, equity market signals, and capacity expansion outlooks: https://lnkd.in/gguBgtia